Freeport-McMoRan (FCX) delivered mixed results in FY2026 on revenue of $158.9B versus the $155.6B estimate (+7.9% YoY) and EPS of $1.83. Below is the full Freeport-McMoRan earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
$158.9B (vs $155.6B est · +2.1% surprise · +7.9% YoY)
EPS
$1.83 (vs $1.84 est · -0.5% surprise · +1.3% YoY)
Share price
$271.94 (+3.4%)
Market cap
$970.0B
What you'll find
Next Freeport-McMoRan (FCX) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Freeport-McMoRan reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Freeport-McMoRan (FCX)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Freeport-McMoRan's next earnings date?
Freeport-McMoRan's (FCX) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Freeport-McMoRan (FCX) beat or miss earnings?
In FY2026, Freeport-McMoRan (FCX) posted mixed results — revenue of $158.9B versus the $155.6B estimate (+2.1% surprise) and EPS of $1.83 versus $1.84 expected (-0.5% surprise). Magnisto decodes every Freeport-McMoRan (FCX) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Freeport-McMoRan (FCX) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Freeport-McMoRan (FCX), anchored to the current $271.94 share price, so you can weigh the bull, base and bear cases for Freeport-McMoRan side by side.
Is Freeport-McMoRan (FCX) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Freeport-McMoRan fits your own thesis and risk profile. This is research, not investment advice.